Journal of Dental Anesthesia and Pain Medicine

The Korean Dental Society of Anesthsiology (대한치과마취과학회)
권호 표지
DOI QR코드

DOI QR Code

Role of dexmedetomidine in pediatric dental sedation

  • Mohite, Vedangi (Department of Pedodontics and Preventive Dentistry, Sharad Pawar Dental College) ;
  • Baliga, Sudhindra (Department of Pedodontics and Preventive Dentistry, Sharad Pawar Dental College) ;
  • Thosar, Nilima (Department of Pedodontics and Preventive Dentistry, Sharad Pawar Dental College) ;
  • Rathi, Nilesh (Department of Pedodontics and Preventive Dentistry, Sharad Pawar Dental College)
  • Received : 2019.04.14
  • Accepted : 2019.04.24
  • Published : 2019.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Dexmedetomidine is a highly selective ${\alpha}2$-adrenoceptor agonist with a vast array of properties, making it suitable for sedation in numerous clinical scenarios. Its use was previously restricted to the sedation of intensive care unit patients. However, its use in pediatric dental sedation has been gaining momentum, owing to its high suitability when compared with conventional pediatric sedatives. Its properties range from sedation to anxiolysis to analgesia, due to its sympatholytic properties and minimal respiratory depression ability. Because dexmedetomidine is an efficacious and safe drug, it is gaining importance in pediatric sedation. Thus, the aim of this review is to highlight the properties of dexmedetomidine, its administration routes, its advantages over the commonly used pediatric sedatives, and especially its role as an alternative pediatric sedative.

Keywords

References

  1. Ramazani N. Different aspects of general anesthesia in pediatric dentistry: A review. Iran J Pediatr 2016; 26: e2613.
  2. Patel V, Singh N, Saksena AK, Singh S, Sonkar SK, Jolly SM. A comparative assessment of intranasal and oral dexmedetomidine for procedural sedation in pediatric dental patients. J Indian Soc Pedod Prev Dent 2018; 36: 370-5. https://doi.org/10.4103/JISPPD.JISPPD_40_18
  3. Devasya A, Sarpangala M. Dexmedetomidine: A review of a newer sedative in dentistry. J Clin Pediatr Dent 2015; 39: 401-9. https://doi.org/10.17796/1053-4628-39.5.401
  4. Chue PS, Chue JA. A review of the clinical uses of dexmedetomidine. Int J Clin Anesthesiol 2017; 5: 1080.
  5. Khan ZP, Ferguson CN, Jones RM. alpha-2 and imidazoline receptor agonists:Their pharmacology and therapeutic role. Anaesthesia 1999; 54: 146-65. https://doi.org/10.1046/j.1365-2044.1999.00659.x
  6. Yuen VM. Dexmedetomidine: perioperative applications in children. Paediatr Anaesth 2010; 20: 256-64. https://doi.org/10.1111/j.1460-9592.2009.03207.x
  7. Bergendahl H, Lonnqvist PA, Eksborg S. Clonidine: an alternative to benzodiazepines for premedication in children. Curr Opin Anaesthesiol 2005; 18: 608-13. https://doi.org/10.1097/01.aco.0000191891.44314.36
  8. Nishina K, Mikawa K, Shiga M, et al. Clonidine in pediatric anesthesia. Paediatr Anaesth 1999; 9: 187-202. https://doi.org/10.1046/j.1460-9592.1999.00379.x
  9. Lonnqvist PA, Bergendahl HT, Eksborg S. Pharmacokinetics of clonidine after rectal administration in children. Anesthesiology 1994; 81: 1097-101. https://doi.org/10.1097/00000542-199411000-00002
  10. Keles S, Kocaturk O. The effect of oral dexmedetomidine premedication on preoperative cooperation and emergence delirium in children undergoing dental procedures. BioMed Res Int 2017; 2017: 6742183.
  11. Mittal NP, Goyal M. Dexmedetomidine: a potential agent for use in procedural dental sedation. Indian J Dent 2014; 5: 21-7. https://doi.org/10.1016/j.ijd.2013.05.005
  12. Surendar MN, Pandey RK, Saksena AK, Kumar R, Chandra G. A comparative evaluation of intranasal dexmedetomidine, midazolam and ketamine for their sedative and analgesic properties: a triple blind randomized study. J Clin Pediatr Dent 2014; 38: 255-61. https://doi.org/10.17796/jcpd.38.3.l828585807482966
  13. Naaz S, Ozair E. Dexmedetomidine in Current Anaesthesia Practice- A Review. J Clin Diagn Res 2014; 8: GE01-4.
  14. Tobias JD, Berkenbosch JW. Initial experience with dexmedetomidine in paediatric-aged patients. Paediatr Anaesth 2002; 12: 171-5. https://doi.org/10.1046/j.1460-9592.2002.00805.x
  15. Karl HW, Rosenberger JL, Larach MG, Ruffle JM. Transmucosal administration of midazolam for premedication of pediatric patients. Comparison of the nasal and sublingual routes. Anesthesiology 1993; 78: 885-91. https://doi.org/10.1097/00000542-199305000-00013
  16. Pimlott SJ, Addy M. Evaluation of a method to study the uptake of prednisolone sodium phosphate from different oral mucosal sites. Oral Surg Oral Med Oral Pathol 1985; 60: 35-7. https://doi.org/10.1016/0030-4220(85)90211-7
  17. Berkenbosch JW, Tobias JD. Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med 2003; 4: 203-5. https://doi.org/10.1097/01.PCC.0000059737.86673.28
  18. Anttila M, Penttila J, Helminen A, Vuorilehto L, Scheinin H. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol 2003; 56: 691-3. https://doi.org/10.1046/j.1365-2125.2003.01944.x
  19. Lammers CR, Rosner JL, Crockett DE, et al. Oral midazolam with an antacid increases the speed of onset of sedation in children prior to general anesthesia. Anesth Analg 1999; 88: S300. https://doi.org/10.1097/00000539-199902001-00297
  20. Sheta SA, Al-Sarheed MA, Abdelhalim AA. Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial. Paediatr Anaesth 2014; 24: 181-9. https://doi.org/10.1111/pan.12287
  21. Jannu V, Mane RS, Dhorigol MG, Sanikop CS. A comparison of oral midazolam and oral dexmedetomidine as premedication in pediatric anesthesia. Saudi J Anaesth 2016; 10: 390-4. https://doi.org/10.4103/1658-354X.177333
  22. Kain ZN, Mayes LC, Wang SM, Caramico LA, Hofstadter MB. Parental presence during induction of anesthesia versus sedative premedication: which intervention is more effective? Anesthesiology 1998; 89: 1147-56. https://doi.org/10.1097/00000542-199811000-00015
  23. Schmidt AP, Valinetti EA, Bandeira D, Bertacchi MF, Simoes CM, Auler JO Jr. Effects of preanesthetic administration of midazolam, clonidine, or dexmedetomidine on postoperative pain and anxiety in children. Paediatr Anaesth 2007; 17: 667-74. https://doi.org/10.1111/j.1460-9592.2006.02185.x
  24. Petroz GC, Sikich N, James M, van Dyk H, Shafer SL, Schily M, et al. A phase I, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology 2006; 105: 1098-110. https://doi.org/10.1097/00000542-200612000-00009
  25. Shukry M, Clyde MC, Kalarickal PL, Ramadhyani U. Does dexmedetomidine prevent emergence delirium in children after sevoflurane-based general anesthesia? Paediatr Anaesth 2005; 15: 1098-104. https://doi.org/10.1111/j.1460-9592.2005.01660.x
  26. Kim J, Kim S, Lee DW, Ryu DS. The alternative of oral sedation for pediatric dental Care. J Dent Anesth Pain Med 2015; 15: 1-4. https://doi.org/10.17245/jdapm.2015.15.1.1
  27. Yuen VM, Hui TW, Irwin MG, Yuen MK. A Comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: a double-blinded randomized controlled trial. Anesth Analg 2008; 106: 1715-21. https://doi.org/10.1213/ane.0b013e31816c8929
  28. Peng K, Wu SR, Ji FH, Li J. Premedication with dexmedetomidine in pediatric patients: a systematic review and meta-analysis. Clinics 2014; 69: 777-86. https://doi.org/10.6061/clinics/2014(11)12
  29. Blaudszun G, Lysakowski C, Elia N, Tramer MR. Effect of perioperative systemic ${\alpha}2$ agonists on postoperative morphine consumption and pain intensity systematic review and meta-analysis of randomized controlled trials. Anesthesiology 2012; 116: 1312-22. https://doi.org/10.1097/ALN.0b013e31825681cb
  30. McGraw T, Kendrick A. Oral midazolam premedication and postoperative behaviour in children. Paediatr Anaesth 1998; 8: 117-21. https://doi.org/10.1046/j.1460-9592.1998.00724.x
  31. Karhuvaara S, Kallio A, Salonen M, Tuominen J, Scheinin M. Rapid reversal of a2-adrenoceptor agonist effects by atipamezole in human volunteers. Br J Clin Pharmacol 1991; 31: 160-5. https://doi.org/10.1111/j.1365-2125.1991.tb05505.x
  32. McCormack L, Chen JW, Trapp L, Job A. A comparison of sedation-related events for two multiagent oral sedation regimens in pediatric dental patients. Pediatr Dent 2014; 36: 302-8.
  33. Levine MF, Spahr-Schopfer IA, Hartley E, Lerman J, MacPherson B. Oral midazolam premedication in children: the minimum time interval for separation from parents. Can J Anaesth 1993; 40: 726-9. https://doi.org/10.1007/BF03009769
  34. Sheta SA, AlSarheed M. Oral midazolam premedication for children undergoing general anaesthesia for dental care. Int J Pediatr 2009; 2009: 274380.
  35. McMillan CO, Spahr-Schopfer IA, Sikich N, Hartley E, Lerman J. Premedication of children with oral midazolam. Can J Anaesth 1992; 39: 545-50. https://doi.org/10.1007/BF03008315

Cited by

  1. Comparative evaluation of a novel herbal anesthetic gel and 2% lignocaine gel as an intraoral topical anesthetic agent in children: Bilateral split-mouth, single-blind, crossover in vivo study vol.38, pp.2, 2019, https://doi.org/10.4103/jisppd.jisppd_226_20
  2. Comparative evaluation of pain perception following topical application of clove oil, betel leaf extract, lignocaine gel, and ice prior to intraoral injection in children aged 6-10 years: a randomized vol.21, pp.4, 2021, https://doi.org/10.17245/jdapm.2021.21.4.329
  3. Circulating microRNA-30a-5p, microRNA-101-3p, microRNA-140-3p and microRNA-141-3p as potential biomarkers for dexmedetomidine response in pediatric patients vol.77, pp.12, 2019, https://doi.org/10.1007/s00228-021-03178-x